Viking Therapeutics to Present at William Blair Biotech Focus Conference 2022

SAN DIEGO, July 6, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D.,…

Click here to view original post